Skip to main content

Healthcare Triangle, Inc.

For the period ended Jun 30, 2025. Filed Aug 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 14, 2025

HCTI$4.21-0.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Unaudited Condensed Consolidated Statements of Operations

Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Net revenue$3,558$2,984$7,263$7,093
Cost of revenue (exclusive of depreciation and amortization shown separately below)3,0642,0866,4405,181
Operating expenses
Research and development55207198334
Sales and marketing6166319901,514
General and administrative1,1829042,3802,080
Depreciation and amortization-534121,070
Total operating expenses1,8532,2763,5804,998
Loss from operations(1,359)(1,378)(2,757)(3,087)
Other income13—124—
Interest expense(21)(131)(435)(280)
Loss before income tax(1,368)(1,509)(3,068)(3,366)
Provision for income tax-(1)-(6)
Net loss$(1,368)$(1,510)$(3,068)$(3,372)
Net loss per common share—basic and diluted(0.58)(70.72)(2.56)(171.85)
Weighted average shares outstanding used in per common share computations:
Basic and diluted (*)2,343,38521,3511,197,82419,622
(*)The Company effected a [1-for-249] reverse split of its issued and outstanding common stock on August 01, 2025. The reverse split reduced the number of issued and outstanding shares of common stock in proportion to the split ratio, without changing the total authorized shares or the par value per share. The basic and diluted earnings consider the effect of reverse split across the reporting periods.

The accompanying notes are an integral part of these unaudited consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.